Mclean Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 185 studies whose lead sponsor is Mclean Hospital. 32 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 14, 2026.
Keep track of what changes. Save the Mclean Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Mclean Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 185. Browse all 185 →
- EEG and Actigraphy Biomarkers of Written Exposure Therapy for Posttraumatic Stress DisorderNot yet recruitingNCT07766798Not applicable
- Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early PsychosisNot yet recruitingNCT07503093Not applicable
- Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101Not yet recruitingNCT07785102Early Phase 1
- Recovery Inspired Support Engagement (RISE) PilotRecruitingNCT07519759Not applicable
- One-Day cTBS Over the PrecuneusRecruitingNCT07758010Not applicable
- Cerebellar Modulation of Cognition in PsychosisRecruitingNCT06107764Not applicable
- Open Label Extension Study of NCT06221852Enrolling by invitationNCT06558201Not applicable
- Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderRecruitingNCT06221852Not applicable
- Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive DisorderNot yet recruitingNCT07593222Phase 1/2
- A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality DisorderRecruitingNCT07460947Phase 1/2
- Single Session Intervention for Postpartum Intrusive ThoughtsNot yet recruitingNCT07725341Not applicable
- Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar DisorderRecruitingNCT05837104Phase 2
- Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and NeglectEnrolling by invitationNCT02757339
- Mechanisms of Exposure Therapy for OCDRecruitingNCT06173752Not applicable
- Mechanisms and Predictors of Change in App-Based Mindfulness Training for AdolescentsRecruitingNCT04697966Not applicable
- Neural Correlates of Stress and Perceived Control in Adolescent DepressionRecruitingNCT04788524Not applicable
- Interpretation Bias as a Mechanism of Treatment Response in OCDRecruitingNCT05224414Not applicable
- Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological ManipulationRecruitingNCT05232032Phase 2
- Pharmacologic Augmentation of TMS for Depression With D-serineRecruitingNCT06876129Phase 1
- Synaptic Mechanisms of Continuous Theta Burst Stimulation in DepressionRecruitingNCT07560878Early Phase 1
- Identifying Substance Use ConsequencesRecruitingNCT07503067
- Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar DisorderRecruitingNCT05457465Phase 2
- Enhanced Coordinated Specialty Care for Early PsychosisRecruitingNCT06071858Not applicable
- Mechanisms of Written Exposure Therapy in Residential SUD TreatmentNot yet recruitingNCT07397507Not applicable
- Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in SchizophreniaRecruitingNCT05343598Not applicable
- Early Life Stress and Depression: Molecular and Functional ImagingRecruitingNCT04713722
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide RibosideRecruitingNCT05245903
- Stress Dynamics and Familial Risk for Depression in Female AdolescentsRecruitingNCT06816329Not applicable
- Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major DepressionRecruitingNCT05630963
- Role of Parent Interpretation Bias in the Transmission of Anxiety to ChildrenRecruitingNCT05665491Not applicable
- MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial DysfunctionRecruitingNCT06191965Phase 2/3
- Individually Targeted Neuromodulation for Contamination-based OCDRecruitingNCT05048251Not applicable
- Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient TraumaActive, not recruitingNCT07868627Phase 2
- Evaluating the Impact of a Novel Cannabinoid Product for EndometriosisActive, not recruitingNCT06477406Phase 2
- Non-Steroidal Anti-Inflammatory Drug (NSAID) Response and Central Sensitization of Pain in Women With DysmenorrheaCompletedNCT05900336Phase 4
- Targeting Orexin to Treat Nicotine DependenceCompletedNCT03999099Phase 1
- Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic DisordersCompletedNCT03943537Phase 2
- Following Outcomes Remotely Within Addiction Recovery DomainsCompletedNCT06001437
- Pain, Inflammation and Opioid CravingCompletedNCT04190563Not applicable
- Electronic Cigarettes and Reactivity to Smoking CuesActive, not recruitingNCT01782599Not applicable
- Development of LabPatch-alcohol as a Noninvasive Skin Patch to Detect Blood Alcohol ConcentrationsActive, not recruitingNCT03242161Early Phase 1
- Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's DementiaCompletedNCT04430517Early Phase 1
- An Intervention to Reduce Discrepancy in Everyday PreferencesWithdrawnNCT03577418Not applicable
- Decision Making, Daily Experiences, and Brain Activity in Young Adult WomenCompletedNCT04125589Not applicable
- Women's Opioid Treatment Follow-up StudyCompletedNCT05776966Not applicable
- Treatment to Enhance Cognition in Bipolar DisorderCompletedNCT01470781Not applicable
- Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's DementiaActive, not recruitingNCT04075435Early Phase 1
- Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar DepressionActive, not recruitingNCT03484494Not applicable
- A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma PatientsTerminatedNCT05753007Phase 2
- Genetic and Neural Predictors of Adolescent DepressionCompletedNCT01743716